Page last updated: 2024-10-21

3-methoxytyramine and Cardiac Remodeling, Ventricular

3-methoxytyramine has been researched along with Cardiac Remodeling, Ventricular in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Research Excerpts

ExcerptRelevanceReference
"Pheochromocytoma is a rare neuroendocrine tumor, clinically characterized by high blood pressure, palpitations, and headache."1.51Electrical Remodeling of Ventricular Repolarization Abnormality after Treatment in Pheochromocytoma: U Wave Finding in a Retrospective Analysis. ( De Luca, G; Di Stolfo, G; Maggio, A; Mastroianno, S; Potenza, DR; Russo, A; Salvatori, MP, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Stolfo, G1
Mastroianno, S1
Maggio, A1
De Luca, G1
Potenza, DR1
Salvatori, MP1
Russo, A1

Other Studies

1 other study available for 3-methoxytyramine and Cardiac Remodeling, Ventricular

ArticleYear
Electrical Remodeling of Ventricular Repolarization Abnormality after Treatment in Pheochromocytoma: U Wave Finding in a Retrospective Analysis.
    BioMed research international, 2019, Volume: 2019

    Topics: Adrenal Gland Neoplasms; Adult; Dopamine; Electrocardiography; Female; Heart Diseases; Humans; Male;

2019